Partner Content Partner Content CAR:T - Has biology outpaced the ability to deliver? Experts comment on manufacturing of CAR-T
Views & Analysis ASH 2017: CAR-T therapy and beyond As the American Society of Hematology’s 2017 congress approaches, there’s plenty to be excited about – not just in blood cancer, but in previously overlooked diseases such as sickle cell anaemi
Events Partner Content Combined CAR-T Congress Europe | 30 - 31 Jan 2018 Hear more about how to maximize CAR-T cell therapy
Events Partner Content CAR-T Congress USA | 20 - 22 March 2018 | Boston Targeting | Commercialization | Scalability
News Cellectis gets FDA go-ahead to restart fatal CAR-T trial Regulator agrees to restart phase 1 trial of UCART 123
News Novartis files CAR-T in Europe in broader use than Gilead ri... Swiss pharma chasing EU licence in NHL and ALL indications
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
